Largest market shown
Germany
$142.2B calculated opportunity across 66 screened products.
Regional export playbook
Bangladesh in Europe
where to look next
Compare buyer markets, access conditions, and product opportunities across Europe. Use this guide to prioritize research, not to treat calculated indicators as guaranteed sales.
3-year opportunity$562.2BCalculated addressable value
Buyer markets26Markets with qualifying rows
FTA markets0Reported access indicator
Avg. distance6,877 kmAverage reported distance
Avg. entry days14Business entry indicator
Europe regional view
Should Bangladesh focus here?
The answer depends on demand, product fit, access, competition, and route economics. This playbook shows where the available trade signals are strongest.
Regional footprint
26 buyer markets
Reported trade and access indicators are available for the qualifying markets shown below.
How to use the guide
Compare demand with access
Start with the strongest markets, then validate buyers, tariffs, standards, logistics, and competition at product level.
Market comparison
Which markets deserve a closer look?
Markets are ranked by calculated three-year opportunity across the qualifying products in this regional view.
| Market | Opportunity | Products | FTA | Distance | Entry days | Top product |
|---|---|---|---|---|---|---|
| GermanyDEU | $142.2B | 66 | Not reported | 7,530 km | 8 | Electric accumulators: lithium-ion, including separators, whether or not rectangular (including square) |
| United KingdomGBR | $77.7B | 32 | Not reported | 8,012 km | 5 | Vehicles: with only electric motor for propulsion |
| NetherlandsNLD | $70.9B | 22 | Not reported | 7,652 km | 4 | Product not reported |
| FranceFRA | $50.8B | 28 | Not reported | 7,917 km | 4 | Aircraft and spacecraft: parts of aeroplanes or helicopters n.e.c. in heading no. 8803 |
| Switzerland, LiechtensteinCHE | $44.9B | 8 | Not reported | 7,596 km | 10 | Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale |
| BelgiumBEL | $30.1B | 9 | Not reported | 7,724 km | 5 | Product not reported |
| PolandPOL | $25.8B | 19 | Not reported | 6,564 km | 37 | Telephones for cellular networks or for other wireless networks |
| CzechiaCZE | $22.8B | 13 | Not reported | 7,032 km | 25 | Telephones for cellular networks or for other wireless networks |
| SloveniaSVN | $21.6B | 3 | Not reported | 7,079 km | 8 | Heterocyclic compounds: n.e.c. in headings no. 2933 |
| ItalyITA | $18.2B | 9 | Not reported | 7,312 km | 11 | Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale |
| SpainESP | $15.1B | 8 | Not reported | 8,661 km | 13 | Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale |
| RussiaRUS | $8.5B | 7 | Not reported | 5,548 km | 10 | Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale |
| AustriaAUT | $6.0B | 4 | Not reported | 6,912 km | 21 | Telephones for cellular networks or for other wireless networks |
| IrelandIRL | $5.4B | 3 | Not reported | 8,344 km | 11 | Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale |
| SwedenSWE | $4.1B | 4 | Not reported | 6,767 km | 8 | Telephones for cellular networks or for other wireless networks |
| DenmarkDNK | $3.2B | 3 | Not reported | 7,103 km | 4 | Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale |
| NorwayNOR | $2.4B | 2 | Not reported | 7,179 km | 4 | Product not reported |
| SlovakiaSVK | $2.2B | 1 | Not reported | 6,853 km | 22 | Telephones for cellular networks or for other wireless networks |
| RomaniaROU | $2.2B | 2 | Not reported | 0 km | 0 | Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale |
| HungaryHUN | $1.9B | 2 | Not reported | 6,718 km | 7 | Electronic integrated circuits: processors and controllers, whether or not combined with memories, converters, logic circuits, amplifiers, clock and timing circuits, or other circuits |
| UkraineUKR | $1.4B | 1 | Not reported | 5,892 km | 7 | Product not reported |
| GreeceGRC | $1.1B | 1 | Not reported | 6,427 km | 4 | Product not reported |
| CroatiaHRV | $1.0B | 1 | Not reported | 6,970 km | 20 | Product not reported |
| LuxembourgLUX | $1.0B | 1 | Not reported | 7,628 km | 17 | Product not reported |
| Bosnia and HerzegovinaBIH | $846.8M | 1 | Not reported | 6,800 km | 80 | Product not reported |
| The former Yugoslav Republic of MacedoniaMKD | $810.5M | 1 | Not reported | 6,575 km | 15 | Product not reported |
Top regional opportunities
Products and markets to review
The rows below are screened by reported buyer demand, exporter position, and available history. Calculated opportunity is a research signal, not a forecast.
| Rank | Market | Product | Opportunity | Buyer growth | Current share |
|---|---|---|---|---|---|
| 1 | Switzerland, LiechtensteinCHE | HS 300490Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $27.7B | +12.3% | +0.0% |
| 2 | GermanyDEU | HS 850760Electric accumulators: lithium-ion, including separators, whether or not rectangular (including square) | $19.8B | +19.2% | +0.0% |
| 3 | BelgiumBEL | HS 271019Product description unavailable | $12.8B | +9.1% | +0.0% |
| 4 | NetherlandsNLD | HS 271019Product description unavailable | $11.9B | +12.2% | +0.0% |
| 5 | SloveniaSVN | HS 293399Heterocyclic compounds: n.e.c. in headings no. 2933 | $10.5B | +30.0% | +0.0% |
| 6 | United KingdomGBR | HS 870380Vehicles: with only electric motor for propulsion | $10.2B | +40.0% | +0.0% |
| 7 | SloveniaSVN | HS 300490Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $9.7B | +17.9% | +0.0% |
| 8 | GermanyDEU | HS 851712Telephones for cellular networks or for other wireless networks | $9.7B | +9.2% | +0.0% |
| 9 | GermanyDEU | HS 847130Data processing machines: portable, digital and automatic, weighing not more than 10kg, consisting of at least a central processing unit, a keyboard and a display | $8.4B | +3.5% | +0.0% |
| 10 | NetherlandsNLD | HS 847130Data processing machines: portable, digital and automatic, weighing not more than 10kg, consisting of at least a central processing unit, a keyboard and a display | $7.3B | +4.0% | +0.0% |
| 11 | BelgiumBEL | HS 300490Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $7.0B | +8.9% | +0.0% |
| 12 | United KingdomGBR | HS 851712Telephones for cellular networks or for other wireless networks | $6.7B | +7.5% | +0.0% |
| 13 | GermanyDEU | HS 851762Communication apparatus (excluding telephone sets or base stations): machines for the reception, conversion and transmission or regeneration of voice, images or other data, including switching and routing apparatus | $6.0B | +11.4% | +0.0% |
| 14 | FranceFRA | HS 880330Aircraft and spacecraft: parts of aeroplanes or helicopters n.e.c. in heading no. 8803 | $5.9B | +6.0% | +0.0% |
| 15 | United KingdomGBR | HS 847130Data processing machines: portable, digital and automatic, weighing not more than 10kg, consisting of at least a central processing unit, a keyboard and a display | $5.7B | +1.9% | +0.0% |
| 16 | GermanyDEU | HS 271012Product description unavailable | $5.6B | +5.8% | +0.0% |
| 17 | CzechiaCZE | HS 851712Telephones for cellular networks or for other wireless networks | $5.5B | +17.1% | +0.0% |
| 18 | NetherlandsNLD | HS 848690Machines and apparatus of heading 8486: parts and accessories | $5.4B | +21.3% | +0.0% |
| 19 | United KingdomGBR | HS 271019Product description unavailable | $5.3B | +8.4% | +0.0% |
| 20 | NetherlandsNLD | HS 300490Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $5.3B | +6.9% | +0.0% |
Sector opportunities
Which product families lead?
HS2 groups make it easier to compare broad product families before moving to individual HS6 products.
HS2 85
HS2 sector 85
65 screened products with $260.1B of reported buyer imports.
$138.8BCalculated opportunity · +9.7% average growthHS2 30
HS2 sector 30
24 screened products with $215.8B of reported buyer imports.
$97.6BCalculated opportunity · +10.3% average growthHS2 84
HS2 sector 84
36 screened products with $133.1B of reported buyer imports.
$80.4BCalculated opportunity · +7.0% average growthHS2 00
HS2 sector 00
27 screened products with $185.0B of reported buyer imports.
$78.5BCalculated opportunity · +8.6% average growthHS2 87
HS2 sector 87
29 screened products with $141.4B of reported buyer imports.
$56.2BCalculated opportunity · +11.2% average growthHS2 71
HS2 sector 71
9 screened products with $35.2B of reported buyer imports.
$16.3BCalculated opportunity · +8.8% average growthHS2 88
HS2 sector 88
5 screened products with $34.4B of reported buyer imports.
$16.2BCalculated opportunity · +8.0% average growthHS2 29
HS2 sector 29
3 screened products with $11.1B of reported buyer imports.
$13.1BCalculated opportunity · +17.1% average growthFrequently asked questions
Using the Europe export playbook
Practical guidance for interpreting regional market and product comparisons.
Should Bangladesh focus on this region?
Use the market ranking as a starting point, then check product fit, buyer requirements, route costs, tariffs, standards, and competitive conditions.
What does calculated opportunity mean?
It is a screening indicator built from demand and exporter-position signals. It is not a confirmed order, sales forecast, or guarantee of market entry.
How should exporters use this page?
Prioritize one market and product combination, then validate buyers, compliance, logistics, pricing, and continuity before making a commercial decision.
Data source
OECD trade statistics with CEPII context
OECD (2025), Balanced international merchandise trade statistics (BIMTS) - HS2017-6D, OECD Data Explorer (accessed on 2026-08-30). OECD BIMTS is the primary trade series for this view. Supporting bilateral trade context uses CEPII BACI bilateral trade flows (202601) under Etalab 2.0 Open Licence. Yugalinks presents derived views of reported observations and calculated indicators. Data terms: OECD Terms & Conditions.